Home/Filings/4/0001415889-24-016874
4//SEC Filing

Avoro Capital Advisors LLC 4

Accession 0001415889-24-016874

CIK 0001422142other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:12 PM ET

Size

10.4 KB

Accession

0001415889-24-016874

Insider Transaction Report

Form 4
Period: 2024-06-12
Avoro Capital Advisors LLC
Director10% OwnerOther
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-12+45,83245,832 total
    Exercise: $1.70Exp: 2034-06-12Common Stock (45,832 underlying)
Aghazadeh Behzad
Director10% OwnerOther
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-12+45,83245,832 total
    Exercise: $1.70Exp: 2034-06-12Common Stock (45,832 underlying)
Avoro Ventures LLC
Director10% OwnerOther
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-12+45,83245,832 total
    Exercise: $1.70Exp: 2034-06-12Common Stock (45,832 underlying)
Footnotes (3)
  • [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024.
  • [F2]This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC.
  • [F3]The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Issuer

Aadi Bioscience, Inc.

CIK 0001422142

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001633313

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:12 PM ET
Size
10.4 KB